These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 782963)
41. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine. Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614 [TBL] [Abstract][Full Text] [Related]
42. Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route. Petrescu AL; Cajal N Virologie; 1984; 35(4):307-14. PubMed ID: 6516213 [TBL] [Abstract][Full Text] [Related]
43. [Live influenza vaccination of military personnel (author's transl)]. Kunz C; Hofmann H; Carda K Wien Klin Wochenschr; 1978 Oct; 90(19):707-10. PubMed ID: 695667 [TBL] [Abstract][Full Text] [Related]
44. The protective effect of intranasal immunization with inactivated influenza virus vaccine. Lien KS; Jacobs J; Marcus EA; Strik RV Postgrad Med J; 1973 Mar; 49(569):175-9. PubMed ID: 4607227 [TBL] [Abstract][Full Text] [Related]
45. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain]. Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538 [No Abstract] [Full Text] [Related]
46. [Prevention of influenza by vaccines administered intramuscularly and intradermally]. Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435 [No Abstract] [Full Text] [Related]
47. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine]. Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019 [TBL] [Abstract][Full Text] [Related]
48. Influenza virus vaccine live intranasal (Aviron). FluMist, influenza vaccine live intranasal. Drugs R D; 1999 Sep; 2(3):204-7. PubMed ID: 10641229 [No Abstract] [Full Text] [Related]
49. The experience of the "Stefan S. Nicolau" Institue of Virology in the preparation of administration of inactivated influenza vaccines applicable by nasal or oral route. Petrescu A; Cajal N; Broniţki A; Mihail A; Teodosiu O; Popescu G; Isaia G; Popescu A Virologie; 1977; 28(3):213-7. PubMed ID: 898654 [TBL] [Abstract][Full Text] [Related]
50. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology. Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C Virologie; 1979; 30(2):109-15. PubMed ID: 111408 [TBL] [Abstract][Full Text] [Related]
51. [Results of intranasal vaccination of school children against influenza by inactivated adinvira vaccine (author's transl)]. Plesník V; Hejná J; Galetková A; Hofta J; Malis J; Sedlácek V; Sekerová Z; Walderová O; Záková E Cesk Epidemiol Mikrobiol Imunol; 1979 Jan; 28(1):1-11. PubMed ID: 156589 [No Abstract] [Full Text] [Related]
52. Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine. Marine WM; Stuart-Harris C J Pediatr; 1976 Jan; 88(1):26-30. PubMed ID: 1245938 [TBL] [Abstract][Full Text] [Related]
53. An attenuated influenza virus vaccine: Reactogenicity, transmissibility, immunogenicity, and protective efficacy. Lauteria SF; Kantzler GB; High PC; Lee JD; Waldman RH J Infect Dis; 1974 Oct; 130(4):380-3. PubMed ID: 4475057 [No Abstract] [Full Text] [Related]
54. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]. Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743 [TBL] [Abstract][Full Text] [Related]
55. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silicate sorbents. I. The immunogenic properties of a vaccine from the A/Victoria/72 strain]. Malafeeva LK; Fridman EA; Zheleznova NV; Polzik TP; Ivanov KG Tr Inst Im Pastera; 1976; 47():124-8. PubMed ID: 210537 [No Abstract] [Full Text] [Related]
56. [Prophylactic effect of live influenza vaccine in a small epidemic of influenza and its evaluation method (author's transl)]. Nakamura K; Okuno Y Uirusu; 1973 Oct; 23(3):185-95. PubMed ID: 4808056 [No Abstract] [Full Text] [Related]
57. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection. Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537 [TBL] [Abstract][Full Text] [Related]
59. WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules. Evans AE; Letley E; Ferris RD; Freestone DS J Hyg (Lond); 1976 Dec; 77(3):327-32. PubMed ID: 1069813 [TBL] [Abstract][Full Text] [Related]
60. Reactogenicity and serologic response to trivalent inactivated A/Texas, A/USSR and B/Hong Kong whole-virus influenza vaccine in human volunteers. Lavergne B; Frappier-Davignon L; Chagnon A; Burr-Paxton M; Quevillon M; Pavilanis V; Beaulnes A Can J Public Health; 1980; 71(1):25-31. PubMed ID: 6991090 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]